Bill Texts: IL HB0077 | 2025-2026 | 104th General Assembly

Bill Title: Amends the Illinois Controlled Substances Act. Schedules xylazine as a Schedule III controlled substance. Provides that notwithstanding the scheduling of xylazine as a Schedule III controlled substance, xylazine shall not be considered a controlled substance when: (1) used by licensed Illinois veterinarians dispensing or prescribing for, or administering to, a nonhuman species of a drug containing xylazine that has been approved by the U.S. Food and Drug Administration; (2) used by licensed Illinois veterinarians dispensing or prescribing for, or administering to, a nonhuman species that is permissible under the Federal Food, Drug, and Cosmetic Act; (3) manufactured, distributed, or used as an active pharmaceutical ingredient for manufacturing an animal drug approved under the Federal Food, Drug, and Cosmetic Act; (4) used by a licensed certified euthanasia technician employed by a certified euthanasia agency; or (5) used by a wildlife biologist engaged in legal or authorized fieldwork under the indirect supervision of a veterinarian.

Sponsorship: Partisan Bill (Republican 5)

Status: (Introduced - Dead) 2025-03-21 - House Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee [HB0077 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2025-01-08HTML/TextLinkView

Amendments

AmendmentDateDispositionFormatSourceView
House Amendment 0012025-02-18ProposedHTML/TextLinkView

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for Illinois HB0077 currently on file.

feedback